Pascal and Francis Bibliographic Databases

Help

Permanent link : http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=25330704

Export

Selection :

A Phase III, Randomized, Placebo-Controlled Study of Belimumab, a Monoclonal Antibody That Inhibits B Lymphocyte Stimulator, in Patients With Systemic Lupus Erythematosus

Author
FURIE, Richard1 ; PETRI, Michelle2 ; STOHL, William11 ; GINZLER, Ellen M12 ; HOUGH, Douglas R13 ; ZHONG, Z. John13 ; FREIMUTH, William13 ; VAN VOLLENHOVEN, Ronald F14 ; ZAMANI, Omid3 ; CERVERA, Ricard4 ; WALLACE, Daniel J5 ; TEGZOVA, Dana6 ; SANCHEZ-GUERRERO, Jorge7 ; SCHWARTING, Andreas8 ; MERRILL, Joan T9 ; CHATHAM, W. Winn10
[1] North Shore―Long Island Jewish Health System, Lake Success, New York, United States
[2] Johns Hopkins University School of Medicine, Baltimore, Maryland, United States
[3] Rheumazentrum Favoriten, Vienna, Austria
[4] Hospital Clinic, Barcelona, Spain
[5] Cedars-Sinai Medical Center/David Geffen School of Medicine at University of California, Los Angeles, United States
[6] Charles University, Prague, Czech Republic
[7] Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubrián, Delegacion Tlalpan, Mexico
[8] Universitatsklinik Mainz, Mainz, Germany, and Sana-Rheumazentrum Rheinland-Pfalz AG, Bad Kreuznach, Germany
[9] Oklahoma Medical Research Foundation, Oklahoma City, United States
[10] University of Alabama, Birmingham, United States
[11] Los Angeles County and University of Southern California Medical Center and University of Southern California Keck School of Medicine, Los Angeles, United States
[12] State University of New York Downstate Medical Center, Brooklyn, United States
[13] Human Genome Sciences, Rockville, Maryland, United States
[14] Karolinska Institute, Stockholm, Sweden
Source

Arthritis and rheumatism. 2011, Vol 63, Num 12, pp 3918-3930, 13 p ; ref : 34 ref

CODEN
ARHEAW
ISSN
0004-3591
Scientific domain
Rheumatology
Publisher
Wiley, Hoboken , NJ
Publication country
United States
Document type
Article
Language
English
Keyword (fr)
Anticorps monoclonal Bélimumab Essai clinique phase III Homme Immunomodulateur Lupus érythémateux disséminé Lymphocyte B Rhumatologie Immunopathologie Maladie autoimmune Maladie de système Pathologie de la peau Pathologie du tissu conjonctif
Keyword (en)
Monoclonal antibody Belimumab Phase III trial Human Immunomodulator Systemic lupus erythematosus B-Lymphocyte Rheumatology Immunopathology Autoimmune disease Systemic disease Skin disease Connective tissue disease
Keyword (es)
Anticuerpo monoclonal Belimumab Ensayo clínico fase III Hombre Inmunomodulador Lupus eritematoso sistémico Linfocito B Reumatología Inmunopatología Enfermedad autoinmune Enfermedad sistémica Piel patología Tejido conjuntivo patología
Classification
Pascal
002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02Q Immunomodulators

Pascal
002 Biological and medical sciences / 002B Medical sciences / 002B07 Sarcoidosis. Granulomatous diseases of unproved etiology. Connective tissue diseases. Elastic tissue diseases. Vasculitis

Pascal
002 Biological and medical sciences / 002B Medical sciences / 002B15 Diseases of the osteoarticular system

Discipline
Osteoarticular pathology Pharmacological treatments Sarcoidosis. Granulomatosis of undetermined origin. Connective tissue diseases. Vasculitides
Origin
Inist-CNRS
Database
PASCAL
INIST identifier
25330704

Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS

Access to the document

Searching the Web